ÂÜÀòÂÒÂ×

Juliano R. Fonseca, PhD is currently the Head of Preclinical Development at Immunic Therapeutics, a NASDAQ-listed company focused on developing oral therapies for chronic inflammatory and auto-immune conditions. Prior to this, Juliano held positions such as Project Manager Bioanalysis at Nuvisan Pharma Services, Analytical Chemistry Scientist at Biocrates Life Sciences AG, and Research Scientist at HelmholtzZentrum München. With a background in chemistry and extensive experience in research and development, Juliano has a strong track record in analytics and preclinical development within the pharmaceutical industry.